- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07766525
Complementary Music Therapy for Pain During Percutaneous Transluminal Angioplasty.
August 18, 2026 updated by: Chang Gung Memorial Hospital
The Effects of Complementary Music Therapy on Intraoperative Pain Reduction for Patients Undergoing Percutaneous Transluminal Angioplasty.
This study evaluated the effectiveness of complementary music therapy in reducing pain among hemodialysis patients undergoing percutaneous transluminal angioplasty (PTA) for arteriovenous fistula dysfunction.
Participants were assigned to either a music intervention group or a control group.
The intervention group listened to self-selected music during the procedure, while the control group received routine care without music.
Pain intensity and physiological parameters, including heart rate, respiratory rate, and blood pressure, were assessed to determine the effects of complementary music therapy during PTA.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Taoyuan
-
Taoyuan, Taoyuan, Taiwan, 333
- Taoyuan Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients scheduled to undergo percutaneous transluminal angioplasty (PTA) under local anesthesia.
- Adults aged 18 years or older who are willing to participate and provide written informed consent.
Exclusion Criteria:
- Patients with impaired consciousness or inability to express their pain perception.
- Patients requiring additional anesthesia or sedation during the procedure due to their clinical condition.
- Patients with hearing impairment or who use hearing aids.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Complementary Music Therapy Group
Participants received complementary music therapy during the PTA procedure in addition to routine care.
Participants listened to self-selected music at 60-80 beats per minute through over-ear headphones from the beginning to the end of the procedure.
|
Participants listened to self-selected music at 60-80 beats per minute through over-ear headphones from the beginning to the end of the PTA procedure, in addition to routine care.
|
|
No Intervention: Routine Care Group
Participants received routine care during the PTA procedure without complementary music therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity Measured by the Visual Analog Scale (VAS)
Time Frame: During the PTA procedure, at up to five balloon inflation time points.
|
Pain intensity was assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, with higher scores indicating greater pain intensity.
Pain was assessed during balloon inflation throughout the PTA procedure.
|
During the PTA procedure, at up to five balloon inflation time points.
|
|
Pain Intensity Measured by the Numeric Rating Scale (NRS)
Time Frame: Immediately after completion of the PTA procedure.
|
Pain intensity was assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, with higher scores indicating greater pain intensity.
After the PTA procedure, participants rated their current pain intensity and retrospectively rated the most and least pain experienced during the procedure.
|
Immediately after completion of the PTA procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate During the PTA Procedure
Time Frame: Before, during, and immediately after the PTA procedure.
|
Heart rate was measured in beats per minute (bpm) before, during, and after the PTA procedure.
During the procedure, measurements were recorded at up to five balloon inflation time points.
|
Before, during, and immediately after the PTA procedure.
|
|
Respiratory Rate During the PTA Procedure
Time Frame: Before, during, and immediately after the PTA procedure.
|
Respiratory rate was measured in breaths per minute before, during, and after the PTA procedure.
During the procedure, measurements were recorded at up to five balloon inflation time points.
|
Before, during, and immediately after the PTA procedure.
|
|
Systolic Blood Pressure During the PTA Procedure
Time Frame: Before, during, and immediately after the PTA procedure.
|
Systolic blood pressure was measured in mmHg before, during, and after the PTA procedure.
During the procedure, measurements were recorded at up to five balloon inflation time points.
|
Before, during, and immediately after the PTA procedure.
|
|
Diastolic Blood Pressure During the PTA Procedure
Time Frame: Before, during, and immediately after the PTA procedure.
|
Diastolic blood pressure was measured in mmHg before, during, and after the PTA procedure.
During the procedure, measurements were recorded at up to five balloon inflation time points.
|
Before, during, and immediately after the PTA procedure.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 24, 2025
Primary Completion (Actual)
November 24, 2025
Study Completion (Actual)
November 24, 2025
Study Registration Dates
First Submitted
August 11, 2026
First Submitted That Met QC Criteria
August 11, 2026
First Posted (Actual)
August 14, 2026
Study Record Updates
Last Update Posted (Actual)
August 20, 2026
Last Update Submitted That Met QC Criteria
August 18, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202402308B0D0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be shared due to participant privacy and confidentiality considerations.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.